Evidence map›Paper›PMID 39999129›Full record

ArticlePloS one2025

A systems analysis and improvement approach to optimizing syringe services programs' delivery of HIV testing and referrals: Study protocol for a parallel-group randomized controlled trial (SAIA-SSP-HIV).

Angela R Bazzi, Alexis M Roth, Christopher F Akiba, Shelby L Huffaker, Sheila V Patel, Jessica Smith, Rose Laurano, Stephen Orme, Gary A Zarkin, Antonio Morgan-Lopez and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06025435 (SAIA-SSP-HIV), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06025435 naactive not recruitingnot on this map

SAIA-SSP-HIV: a Systems Analysis and Improvement Approach to Optimizing HIV Service Delivery in Syringe Services Programs

TypeinterventionalSponsorUniversity of California, San DiegoRan2023 to 2027Enrolled32ConditionsHIV InfectionsArmsSAIA-HIV-SSP
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Angela R BazziHerbert Wertheim School of Public Health, University of California San Diego, La Jolla, California, United States of America.ORCID 0000-0001-6828-1919
Alexis M RothDornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, United States of America.
Christopher F AkibaRTI International, Research Triangle Park, Durham, North Carolina, United States of America.
Shelby L HuffakerBoston University School of Public Health, Boston, Massachusetts, United States of America.
Sheila V PatelRTI International, Research Triangle Park, Durham, North Carolina, United States of America.
Jessica SmithRTI International, Research Triangle Park, Durham, North Carolina, United States of America.
Rose LauranoDornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, United States of America.
Stephen OrmeRTI International, Research Triangle Park, Durham, North Carolina, United States of America.
Gary A ZarkinRTI International, Research Triangle Park, Durham, North Carolina, United States of America.ORCID 0000-0003-3331-0788
Antonio Morgan-LopezRTI International, Research Triangle Park, Durham, North Carolina, United States of America.
Barrot H LambdinRTI International, Research Triangle Park, Durham, North Carolina, United States of America.ORCID 0000-0001-8546-0126

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programsR01DA056883 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON, LAMBDIN, BARROT HOPKINS · 2022 to 2025
$3.4M
NIAID NIH HHS P30 AI036214NIDA NIH HHS R01 DA056883
6 · The paper itself

Abstract

With changing drug supplies and associated drug consumption behaviors, HIV transmission has increased among people who inject drugs in the United States. HIV testing and referrals to effective prevention and treatment services are critical for individual and population health, yet multilevel barriers limit access to HIV testing for this population, even within syringe services programs (SSPs). In this organizational-level interrupted time series randomized controlled trial, we will assess the effectiveness and cost-effectiveness of an implementation strategy, the Systems Analysis and Improvement Approach (SAIA), in optimizing HIV testing and referrals to appropriate clinical services among U.S. SSPs. From 01/12/2023 to 01/07/2025, we will recruit a diverse sample of 32 SSPs nationally that directly provide HIV testing to participants. SSPs will be randomized to the active implementation arm (i.e., SAIA-SSP-HIV) or an implementation-as-usual arm (n = 16 organizations per arm). SAIA-SSP-HIV is a flexible, data-driven implementation strategy designed to help optimize SSPs' delivery of HIV testing and referrals to appropriate clinical services for HIV prevention (e.g., pre-exposure prophylaxis) and treatment. In the active implementation arm, trained SAIA specialists will guide SSPs through three cyclical steps over 12 months: (1) process mapping to identify organization-specific needs, (2) cascade analysis and prioritization of areas for improvement, and (3) testing solutions through continuous quality improvement. In both arms, we will collect outcome data over 21 months (3-month lead-in period, 12-month implementation period, 6-month sustainment period). We will assess the initial and sustained effectiveness of SAIA and calculate its cost and cost-effectiveness. This trial presents a novel opportunity to test the effectiveness of an organization-level implementation strategy for optimizing the delivery of HIV screening and referrals in community settings that are frequented by an at-risk population. If successful, SAIA-SSP-HIV could be adapted for other infectious or chronic disease care cascades within SSPs. Trial registration: ClinicalTrials.gov: NCT06025435.

Indexed as

HIV InfectionsHIV TestingNeedle-Exchange ProgramsReferral and ConsultationSystems AnalysisCost-Benefit AnalysisHumansRandomized Controlled Trials as TopicSubstance Abuse, IntravenousUnited States

Identifiers

PMID39999129
PMCPMC11856318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.